Drug Approvals
🇺🇸 FDA Page 33FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 385–396 of 665 articles
FDA to Consider Lifting Restrictions on Compounded Peptides
Streamlined R&D at Novo Nordisk: Insights from Research Chief Petersen
The Current Landscape of Consumer Health: Insights and Implications
Marc Tessier-Lavigne Responds to Allegations: Implications for Pharma
NIH Leadership Gaps: Implications for the Pharma Industry
BioMarin Drug Acquisition: Missed Goals in Rare Disease Study
WHO's Defense of Ebola Response: Implications for Pharma
The Next Big Pharma Company Will Emerge from China
Amgen's CFO Departure: Implications for Pharma Industry
Oorja Launches New Fibrosis Drugs: Insights from Acceleron Veterans
Relay's PI3Kα Inhibitor Shows Promise in Phase 2 Study
Future Uses for CGM: Insights from Dexcom's CEO